UnitedHealth Group Incorporated $UNH Stake Raised by Benjamin Edwards Inc.

Benjamin Edwards Inc. raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 4.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 81,468 shares of the healthcare conglomerate’s stock after purchasing an additional 3,502 shares during the quarter. Benjamin Edwards Inc.’s holdings in UnitedHealth Group were worth $29,916,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the business. BlackRock Inc. increased its position in shares of UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after purchasing an additional 3,395,530 shares during the last quarter. State Street Corp boosted its stake in UnitedHealth Group by 0.7% during the second quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock worth $18,966,555,000 after buying an additional 301,081 shares during the period. Bank of America Corp DE increased its position in UnitedHealth Group by 21.8% during the first quarter. Bank of America Corp DE now owns 11,713,684 shares of the healthcare conglomerate’s stock valued at $3,169,606,000 after acquiring an additional 2,097,859 shares during the last quarter. Fisher Asset Management LLC boosted its stake in shares of UnitedHealth Group by 19.2% during the 3rd quarter. Fisher Asset Management LLC now owns 10,829,637 shares of the healthcare conglomerate’s stock worth $3,975,343,000 after purchasing an additional 1,747,368 shares during the period. Finally, Bank of New York Mellon Corp grew its holdings in UnitedHealth Group by 6.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock valued at $4,449,317,000 after purchasing an additional 616,723 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have issued reports on UNH. UBS Group reissued an “outperform” rating on shares of UnitedHealth Group in a research note on Tuesday, October 13th. Morgan Stanley increased their price target on UnitedHealth Group from $529.00 to $531.00 and gave the stock an “overweight” rating in a report on Tuesday, October 27th. HC Wainwright set a $500.00 price target on UnitedHealth Group in a research note on Friday, October 16th. KeyCorp reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Wednesday, October 14th. Finally, Robert W. Baird decreased their target price on UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating for the company in a research report on Wednesday, October 14th. Twenty-one analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $465.70.

View Our Latest Report on UNH

Recent UnitedHealth Group Headlines

Investors following UNH have been watching these headlines:

UnitedHealth Group Trading Up 2.9%

NYSE:UNH opened at $339.92 on Friday. The company has a market capitalization of $304.57 billion, a P/E ratio of 19.41, a PEG ratio of 1.23 and a beta of 0.51. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62. The firm has a fifty day simple moving average of $388.64 and a 200-day simple moving average of $367.55.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The company had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. During the same quarter last year, the business posted $2.59 EPS. The firm’s quarterly revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be issued a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio is 53.00%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.